{
"NDC": {
"NDCCode": "57664-993-01",
"PackageDescription": "13 mL in 1 BOTTLE (57664-993-01) ",
"NDC11Code": "57664-0993-01",
"ProductNDC": "57664-993",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Deflazacort Oral Suspension",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Deflazacort Oral",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20260202",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA219930",
"LabelerName": "Sun Pharmaceutical Industries, Inc.",
"SubstanceName": "DEFLAZACORT",
"StrengthNumber": "22.75",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-02-02",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260202",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}